Issue
Alert me when new journal issues are available via or via
Letter from the editors Leonard M. Freeman, M.Donald Blaufox page 1 Full Text | Full-Text PDF (20 KB)
Radioimmunotherapy with Yttrium 90 ibritumomab tiuxetan (Zevalin): The role of the nuclear medicine physician Peter S. Conti pages 2-3 Abstract | Full Text | Full-Text PDF (33 KB)
Safety and efficacy of radioimmunotherapy with Yttrium 90 ibritumomab tiuxetan (Zevalin) Hossein Borghaei, Russell J. Schilder pages 4-9 Abstract | Full Text | Full-Text PDF (85 KB)
Imaging and dosing in radioimmunotherapy with Yttrium 90 ibritumomab tiuxetan (Zevalin) Stewart M. Spies pages 10-13 Abstract | Full Text | Full-Text PDF (132 KB)
Logistics of radioimmunotherapy with Yttrium 90 ibritumomab tiuxetan (Zevalin) A.Michael Zimmer pages 14-19 Abstract | Full Text | Full-Text PDF (252 KB)
Radiation safety considerations with yttrium 90 ibritumomab tiuxetan (Zevalin) Xiaowei Zhu pages 20-23 Abstract | Full Text | Full-Text PDF (200 KB)
Table of contents page RF1 Full Text | Full-Text PDF (13 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
